Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 3,962 shares at $274.08 ($1.1M) on 2017-04-03, disclosed to the SEC on 2017-04-04.
Open-market sale of $1.1M BIIB by EVP CMO Neuro & Neurodegenerat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $274.08 | 1,981 | $543K | 50.0% |
| 2 | $274.08 | 1,981 | $543K | 50.0% |
| Total | $274.08 avg | 3,962 | $1.1M | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |